Stay updated on Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial page.
Latest updates to the Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
- Check19 days agoChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe website has removed a detailed section regarding data download options and study information fields, which may affect users looking for specific data formats and study details.SummaryDifference13%
- Check41 days agoChange DetectedSeveral key government health and information websites have been removed from the monitored list.SummaryDifference0.7%
- Check48 days agoChange DetectedThe website has been updated to version 2.12.2, adding several new resource links and enhancing the data download options, while the previous version 2.12.1 has been removed.SummaryDifference17%
- Check55 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.3%
Stay in the know with updates to Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial page.